Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis

Details for Australian Patent Application No. 2012203578 (hide)

Owner Vascular Biogenics Ltd.

Inventors Harats, Dror; Greenberger, Shoshana; Breitbart, Eyal; Bangio, Livnat; Peled, Michael

Agent Cullens

Pub. Number AU-A-2012203578

Parent 2011205076

Filing date 15 June 2012

Wipo publication date 12 July 2012

International Classifications

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 7/01 Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 15/00 Mutation or genetic engineering

C12P 21/00 Preparation of peptides or proteins

Event Publications

5 July 2012 Complete Application Filed

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203578

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203579-A System and Method for Improving Hospital Patient Care by Providing a Continual Measurement of Health

2012203577-Stents having biodegradable layers